Discover 1,881 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,881
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: St. John's, Halifax, Bangor ME, Portland ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase3, Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Norfolk VA, Fairfax VA, Atlanta GA, Nashville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07266441
Phase2, Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase2, Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: New York NY, Charlottesville VA, Tampa FL, Atlanta GA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06911112
Phase3, Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Riverhead NY, Patchogue NY, Port Jefferson Station NY,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
for
Colorectal Cancer, Sarcopenia
Location: Millville DE, Rehoboth Beach DE, Wilmington DE,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 60+
Code: NCT03998202
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Boston MA, Providence RI, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
for
Nasopharyngeal Cancer Recurrent
Location: Boston MA, Hershey PA, Toronto, Cleveland OH,
Sponsor: Coherus Oncology, Inc.
Sex: All
Age: 12+
Code: NCT06457503
Recruiting
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
for
Duchenne Muscular Dystrophy, Exon 44, DMD
Location: Philadelphia PA, Richmond VA, Pittsburgh PA,
Sponsor: NS Pharma, Inc.
Sex: Male
Age: 4 - 14
Code: NCT05996003
Phase2, Recruiting
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: New York NY, Baltimore MD, Marietta GA, Richmond VA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT06920043
Phase2, Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Moncton, Portland ME, Boston MA, New Haven CT,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00358943
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.